The FDA has given an update on its ongoing review of a possible link between GLP-1 agonist drugs used to treat diabetes and obesity and suicide ... Ozempic for diabetes and obesity therapy Wegovy ...

The review follows a recent federally funded study that showed that people taking semaglutide, the medication in Ozempic and Wegovy, had a lower risk of suicidal thoughts than those taking other ...

It looked into several big-selling therapies, including Novo Nordisk’s Ozempic for diabetes and obesity therapy Wegovy ... which also found no link with thoughts of suicide or self-injury ...

Researchers say they have uncovered a link between semaglutide — the active ingredient in Ozempic and Wegovy — and sudden ... There are no effective treatments for NAION.

Adverse reactions to the likes of Ozempic and Wegovy are set to soar by more than 350% in a single year, according to the ...